Good news for all of us supporting implementation of pharmacogenomics into clinical practise: EMA and BfArM recommend genetic testing before having a chemotherapy.
bio.logis will take part in both meetings and our team looks forward to exchanging ideas with you. At the 5th German PharmTox summit we will have a presentation on GIMS.pharma as part of the "Meet the Company" session.
„We are convinced, that the Diagnostic Report Module of the bio.logis Genetic Information Management Suite will improve the process of creating more valuable results, which we provide to our clients (i.e. physicians). This will help us to build a competition advantage.“
"bio.logis is the ideal partner for us to implement personalized pharmacogenetic diagnostics.
We know the GIM system from the EU project Ubiquitious Pharmacogenomics, in which it has already proven its efficiency."